ADAM STREB: Open Payments
NPI 1972733400 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 17 payments from 8 companies in 2025. Trend: 2023 $390 · 2024 $408 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $111 |
| PFIZER INC. | 4 | $80 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| Kestra Medical Technology Services, Inc. | 1 | $35 |
| Boston Scientific Corporation | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
Products named: EVKEEZA, JARDIANCE, LEQVIO, ELIQUIS, Assure WCD, NURTEC ODT, WATCHMAN FLX, VERQUVO.
Industry payments across NY — which companies pay providers there.
